Literature DB >> 7181489

Two-compartment comparison of gentamicin and tobramycin in normal volunteers.

M Adelman, E Evans, J J Schentag.   

Abstract

The objective of this study was to determine whether differences in tissue accumulation observed upon multiple dosing of aminoglycosides in hospitalized patients could be identified in appropriate single-dose studies in normal volunteers. Ten volunteers received single intravenous doses of 1.0 mg of gentamicin and tobramycin per kg of body weight in randomized crossover fashion. Multiple serum and urine samples were collected during the next 30 days. Serum aminoglycoside concentrations and urinary excretion rates were fitted to a two-compartment pharmacokinetic model, and parameters were derived. Tobramycin exhibited a higher clearance (P less than 0.08) and a lower volume of distribution at steady state (P less than 0.1), neither of which was significant. Tobramycin also showed a significantly lower predicted amount of drug in the body at steady state (P less than 0.05). These differences are consistent with observations made in patients receiving multiple doses. Single-dose studies appear to be capable of discriminating pharmacokinetic characteristics relevant to the comparative nephrotoxic potential of these two aminoglycosides.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7181489      PMCID: PMC185663          DOI: 10.1128/AAC.22.5.800

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Renal clearance and tissue accumulation of gentamicin.

Authors:  J J Schentag; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1977-09       Impact factor: 6.875

2.  Gentamicin: toxicity in perspective.

Authors:  W L Hewitt
Journal:  Postgrad Med J       Date:  1974-11       Impact factor: 2.401

3.  Biochemical and immunological studies on isolated brush border membranes of human kidney cortex and their membrane surface proteins.

Authors:  J E Scherberich; F W Falkenberg; A W Mondorf; H Müller; G Pfleiderer
Journal:  Clin Chim Acta       Date:  1974-09-16       Impact factor: 3.786

4.  Multiple-compartment pharmacokinetics of tobramycin.

Authors:  G Kahlmeter; S Jonsson; C Kamme
Journal:  J Antimicrob Chemother       Date:  1978-05       Impact factor: 5.790

5.  Comparative tissue accumulation of gentamicin and tobramycin in patients.

Authors:  J J Schentag; G Lasezkay; M E Plaut; W J Jusko; T J Cumbo
Journal:  J Antimicrob Chemother       Date:  1978-05       Impact factor: 5.790

6.  Netilmicin: clinical efficacy, tolerance, and toxicity.

Authors:  A P Panwalker; J B Malow; V M Zimelis; G G Jackson
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

7.  Accumulation pharmacokinetics of tobramycin.

Authors:  J J Schentag; G Lasezkay; T J Cumbo; M E Plaut; W J Jusko
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

8.  Natural history of aminoglycoside nephrotoxicity in the dog.

Authors:  R E Cronin; R E Bulger; P Southern; W L Henrich
Journal:  J Lab Clin Med       Date:  1980-03

9.  Gentamicin tissue accumulation and nephrotoxic reactions.

Authors:  J J Schentag; T J Cumbo; W J Jusko; M E Plaut
Journal:  JAMA       Date:  1978-11-03       Impact factor: 56.272

10.  Urinary casts as an indicator of renal tubular damage in patients receiving aminoglycosides.

Authors:  J J Schentag; F M Gengo; M E Plaut; D Danner; A Mangione; W J Jusko
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

View more
  6 in total

1.  A discriminatory study of a pharmacokinetic model for intramuscular gentamicin in sheep.

Authors:  J O Errecalde; E L Mariño
Journal:  Vet Res Commun       Date:  1990       Impact factor: 2.459

2.  Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.

Authors:  Aline Fuchs; Monia Guidi; Eric Giannoni; Dominique Werner; Thierry Buclin; Nicolas Widmer; Chantal Csajka
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

Review 3.  Adverse effects of a single dose of gentamicin in adults: a systematic review.

Authors:  Rachel S Hayward; Jan Harding; Rob Molloy; Lucy Land; Kate Longcroft-Neal; David Moore; Jonathan D C Ross
Journal:  Br J Clin Pharmacol       Date:  2017-11-03       Impact factor: 4.335

Review 4.  Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.

Authors:  R de Groot; A L Smith
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

5.  Altered tobramycin pharmacokinetics during chemoprophylaxis in bladder surgery.

Authors:  F Bressolle; P Joubert; A Gouby; P Costa; M Laracine; T Rebière
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

6.  Single-dose accumulation pharmacokinetics of tobramycin and netilmicin in normal volunteers.

Authors:  N E Winslade; M H Adelman; E J Evans; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.